Clinical trials
Observational Lymphoma, Large B-Cell, Diffuse trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ruijin Hospital | 4 |
| Sun Yat-sen University | 3 |
| Hospices Civils de Lyon | 2 |
| Peking Union Medical College Hospital | 2 |
| Ajou University School of Medicine | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| Fudan University | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Fundación Academia Española de Dermatología | 1 |
| German High-Grade Non-Hodgkin's Lymphoma Study Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 29 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Lymphoma | 2 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Extranodal NK-T-Cell | 2 |
| Lymphoma, T-Cell, Peripheral | 2 |
| Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.